Literature DB >> 2032314

Albuminuria vs urinary total protein for detecting chronic renal disorders.

Z K Shihabi1, J C Konen, M L O'Connor.   

Abstract

A literature review and our own data are presented to demonstrate that urinary albumin (UA) excretion increases in many renal disorders and that it offers a far more sensitive indicator than the commonly used urinary total protein (UTP) for the early detection of renal involvement in many chronic diseases such as diabetes mellitus, hypertension, and systemic lupus erythematosus. In many individuals with these disorders, UA increases severalfold, even while UTP remains within the reference interval. UA is also more suited than UTP for following therapeutic responses in these slowly progressive renal disorders. Increases in UA are associated with increased mortality. UTP measurements are plagued with many analytical problems, whereas UA is much easier to standardize. We recommend that both UA and UTP be measured when quantitative urine protein assays are ordered, especially when the UTP is less than 300 mg/g of creatinine.

Entities:  

Mesh:

Year:  1991        PMID: 2032314

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Urine albumin, total protein, and glomerular proteinuria.

Authors:  F C Ballantyne; D S O'Reilly
Journal:  BMJ       Date:  1992-06-06

2.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

3.  Measurement of the albumin content of urinary protein using dipsticks.

Authors:  M Sasaki; M J Pugia; D R Parker; K Kuromoto; I Furukawa; I Konishi
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Authors:  David M Good; Petra Zürbig; Angel Argilés; Hartwig W Bauer; Georg Behrens; Joshua J Coon; Mohammed Dakna; Stéphane Decramer; Christian Delles; Anna F Dominiczak; Jochen H H Ehrich; Frank Eitner; Danilo Fliser; Moritz Frommberger; Arnold Ganser; Mark A Girolami; Igor Golovko; Wilfried Gwinner; Marion Haubitz; Stefan Herget-Rosenthal; Joachim Jankowski; Holger Jahn; George Jerums; Bruce A Julian; Markus Kellmann; Volker Kliem; Walter Kolch; Andrzej S Krolewski; Mario Luppi; Ziad Massy; Michael Melter; Christian Neusüss; Jan Novak; Karlheinz Peter; Kasper Rossing; Harald Rupprecht; Joost P Schanstra; Eric Schiffer; Jens-Uwe Stolzenburg; Lise Tarnow; Dan Theodorescu; Visith Thongboonkerd; Raymond Vanholder; Eva M Weissinger; Harald Mischak; Philippe Schmitt-Kopplin
Journal:  Mol Cell Proteomics       Date:  2010-07-08       Impact factor: 5.911

5.  Sleep-disordered breathing and urinary albumin excretion in older men.

Authors:  Muna T Canales; Misti L Paudel; Brent C Taylor; Areef Ishani; Reena Mehra; Michael Steffes; Katie L Stone; Susan Redline; Kristine E Ensrud
Journal:  Sleep Breath       Date:  2010-02-26       Impact factor: 2.816

Review 6.  Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.

Authors:  Tobias Christian Fuchs; Philip Hewitt
Journal:  AAPS J       Date:  2011-10-04       Impact factor: 4.009

7.  Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30-40 days of postnatal corrected age.

Authors:  Maria Cristina Aisa; Benito Cappuccini; Antonella Barbati; Aldo Orlacchio; Mauro Baglioni; Gian Carlo Di Renzo
Journal:  Pediatr Nephrol       Date:  2016-08-25       Impact factor: 3.714

8.  Value of urinary excretion of microalbumin in predicting glomerular lesions in children with isolated microscopic hematuria.

Authors:  Farahnak K Assadi
Journal:  Pediatr Nephrol       Date:  2005-06-08       Impact factor: 3.714

9.  CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.

Authors:  Joshua J Coon; Petra Zürbig; Mohammed Dakna; Anna F Dominiczak; Stéphane Decramer; Danilo Fliser; Moritz Frommberger; Igor Golovko; David M Good; Stefan Herget-Rosenthal; Joachim Jankowski; Bruce A Julian; Markus Kellmann; Walter Kolch; Ziad Massy; Jan Novak; Kasper Rossing; Joost P Schanstra; Eric Schiffer; Dan Theodorescu; Raymond Vanholder; Eva M Weissinger; Harald Mischak; Philippe Schmitt-Kopplin
Journal:  Proteomics Clin Appl       Date:  2008-07-10       Impact factor: 3.494

10.  Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria.

Authors:  Sten Andersen; Harald Mischak; Petra Zürbig; Hans-Henrik Parving; Peter Rossing
Journal:  BMC Nephrol       Date:  2010-11-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.